Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Jobs
 

EquipNet Auction: Tarveda Therapeutics Major Lab Site Closure, June 9 @ 9 am EST

Check Out Our New Cartoon Celebrating Asian American & Pacific Islander History Month


Utah Life Science Industry Directory

National Cancer Research Month

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2022 replacing UtahLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

EyeGate Pharmaceuticals, Inc


EyeGate Pharmaceuticals, Inc
675 Arapeen Dr., Suite 302
Salt Lake City, UT 84108-1228
EyeGate Pharmaceuticals, Inc
 
Phone: (617) 926-5000
Fax: (617) 926-5050
Year Established:  2011
Ticker: EYEG
Exchange: NASDAQ
Main Contact: Nancy Lurker, President & CEO
 
Company Description
EyeGate, formerly Jade Therapeutics, is focused on developing therapeutics designed to address two major issues in ophthalmic medicine, patient compliance and patient throughput. EyeGate features a small, elegant, and easy-to-use device that delivers drugs non-invasively and quickly into the ocular tissues, which can dramatically increase the onset of action. The procedure only takes a few minutes and can be administered by all eye care practitioners. The EyeGate® II Delivery System is compatible with a wide range of therapeutics and has the potential to address many anterior and posterior segment diseases. Over 1,200 treatments have been performed with the EyeGate® II Delivery System and it is the first ocular iontophoresis system to have completed Phase II studies (Dry Eye and Uveitis), and a Phase III study (Dry Eye).


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

UtahLifeScience.com is owned and published by Info.Resource, Inc.